Biotechnology Companies in Riley Park/South Cambie, Vancouver, BC
Find accurate info on the best businesses belonging to the Biotechnology Companies category in Vancouver. Get reviews and contact details for each business, including phone number, address, opening hours, promotions and other information.
Showing results: 1 - 1 out of 1
Showing results: 1 - 1 out of 1
Results from the 'Biotechnology Companies' category in Riley Park/South Cambie, Vancouver
5740 Cambie St # 33, RILEY PARK/SOUTH CAMBIE, Vancouver, V5Z 3A6
(604) 327-2033
BC Biomedical Laboratories Ltd. is the largest physician-owned (Dr. C.J. Coady Associates) and operated laboratory in British Columbia. Each year, more than 1.9 million patients visit one of our 45 Patient Service Centres throughout the Lower Mainland. Nearby results from the Biotechnology Companies category
8755 Ash Street, MARPOLE, Vancouver, V6P 6T3
(604) 323-2547
Medical laboratory, Biotechnology company, Medical Lab, Medical Service 
Open now
#116-408 East Kent Avenue South, Vancouver, V5X 2X7
Biotechnology company, Alternative & Holistic Health Service 
Open now
Suite 720 - 999 West Broadway, Vancouver, V5Z 1K5
(604) 629-5989
DelMar Pharmaceuticals is a clinical and commercial stage drug development company with a focus on the treatment of cancer. We are conducting clinical trials in the United States with our product candidate, VAL-083, as a potential new treatment for glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. We have also acquired certain exclusive commercial rights to VAL-083 in China where it is approved as a chemotherapy for the treatment of chronic myelogenous leukemia (CML) and lung cancer. 
400 - 570 - 7Th Ave W, Vancouver, V5Z 1B3
(604) 877-0713
Biotechnology company 
Open now
1285 West Broadway, Suite 600, Vancouver, V6H 3X8
(604) 551-6782
Pharmacy Drugstore, Biotechnology company 
Open now
2131 Manitoba St, Vancouver, V5Y 0N7
(604) 263-0502
Aspect Biosystems is a Canadian biotechnology company founded in November, 2013. The company spun out from two internationally recognized research groups in engineering and medicine at the University of British Columbia. Aspect Biosystems is working towards a future where doctors determine which drugs work for their patients before prescribing them, where animals are no longer needed for the development of new therapeutics, and where lifesaving transplant organs are created, not harvested. To realise these goals, Aspect has developed a disruptive 3D bioprinting platform technology capable of creating living human tissues on demand. Our initial products aim to improve the predictive accuracy of the pre-clinical drug discovery process by providing the industry and researchers with the technology to create highly customized physiologically-relevant 3D human tissue models that they can employ in the development of new drugs. Aspect’s technology has the potential to drive a fundamental shift in the pharmaceutical industry, enabling the development of completely new therapeutics, and enabling pharma to test drugs they may have shelved in the past due to a lack of appropriate models. Furthermore, Aspect’s technology has the potential to significantly reduce the use of laboratory animals, supporting an industry wide mandate to reduce, refine and replace animal testing. Aspect has a long-term vision to expand beyond applications in drug development, by enabling Human Tissues on Demand™ for broad applications in the life sciences including regenerative medicine and organ transplantation. 
Open now
887 Great Northern Way, suite 220, Vancouver, V5T 4T5
(604) 674-1796
Biotechnology company 
Open now
887 Great Northern Way, Suite 220, Vancouver, V5T 4T5
(604) 637-3280
Biotechnology company 
210-887 Great Northern Way, Vancouver, V5T 4T5
(604) 343-1552
Biotechnology company 
